Shopping Cart 0
Cart Subtotal
USD 0

Global Neurovascular Devices Market Research Report: Product (Aneurysm Coiling & Embolization Devices, Support Device) Therapeutic Application (Hemorrhagic & Ischemic Strokes) End-User (Hospitals, Ambulatory Surgical Units) - Global Forecast Till 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4450

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 6250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Global Neurovascular Devices Market Research Report: Product (Aneurysm Coiling & Embolization Devices, Support Device) Therapeutic Application (Hemorrhagic & Ischemic Strokes) End-User (Hospitals, Ambulatory Surgical Units)-Global Forecast Till 2023

Market Analysis

For the treatment of neurovascular diseases like arteriovenous malformations (AVMs), brain aneurysm, and others, the neurovascular devices are used. With the expanding worldwide burden of the neurovascular illnesses and rising interest for negligibly invasive systems, the market for neurovascular gadgets was created. The market keeps on developing these reasonable stages. Furthermore, factors, for example, good repayment strategies, and continuous product development and commercialization drive market development. Hence, the global market for neurovascular devices is relied upon to develop at an exponential rate amid the forecast period (2017-2023).

Nevertheless, high procedural expense pursued by revealed instances of damage and the requirement for doctor preparing is assessed to control the market development amid the gauge time frame. It is accounted for that the normal expense for the treatment of neurovascular devices utilizing the flow diversion is assessed to be about USD 24,650. The Global Neurovascular Devices Market is projected to grow at a CAGR of 8.8% during forecast period.

Market Segmentation

The global neurovascular devices market is divided on the basis of product, end-user, therapeutic application, and regional analysis. Based on its product, the market is classified into embolization devices & aneurysm coiling, support device, neuro thrombectomy devices, stenting systems, and cerebral balloon angioplasty. Based on its therapeutic application, the global neurovascular devices market is categorized into ischemic strokes and hemorrhagic stroke. On the basis of the end-users industry, the market is classified into ambulatory surgical units and hospitals & clinics.

Regional Analysis

Geographically, the global neurovascular devices market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major Players

The industry players for the global neurovascular devices market include companies like Stryker, Johnson & Johnson Services, Inc., Medtronic, TERUMO CORPORATION, Merit Medical Systems, Inc., Abbott, Medikit co., ltd., MicroPort Scientific Corporation, Penumbra, Inc., Evasc, Neuravi, Rapid Medical, W. L. Gore & Associates, Inc., Sensome, OxfordEndovascular, Blockade Medical, LLC., Secant Group, LLC, Delaware Corporation, Gynesonics, among others.

READ MORE

Table Of Content

Scope

Table of Contents:

1 Report Prologue

1.1 Introduction

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.4.1 Assumptions

1.4.2 Limitations

2 Research Methodology

2.1.1 Primary Research Methodology

2.1.2 Secondary Research Methodology

2.1.3 Market Share Analysis

2.1.4 Market Pricing Approach

3 Market Dynamics

3.1 Introduction

3.2 Drivers

3.2.1 Increasing prevalence of neurovascular diseases like brain aneurysm, arteriovenous malformations (AVMs), and others, will propel the neurovascular devices market

3.2.2 Favourable reimbursement policies provide favorable background for market growth

3.2.3 Rising demands for minimally invasive therapeutic procedures and growing geriatric population will drive the neurovascular devices market growth

3.2.4 Ongoing product development & commercialization will boost the neurovascular devices market

3.3 Restraints

3.3.1 High procedural cost by neurovascular devices

3.3.2 Cases of injury and need for physician training

3.4 Opportunity

3.5 Mega trend

3.5.1.1 Increasing use of endovascular embolization for the treatment of brain aneurysm

3.6 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Value Chain Analysis

4.1.1 R&D and Designing

4.1.2 Manufacturing

4.1.3 Distribution & Sales

4.1.4 Post-Sales Review

4.2 Porter's Five Forces Model

4.2.1 Bargaining Power of Suppliers

4.2.2 Bargaining Power of Buyers

4.2.3 Threat of New Entrants

4.2.4 Threat of Substitutes

4.2.5 Intensity of Rivalry

4.3 Investment Opportunities

4.4 Pricing Analysis

4.5 Demand & Supply: Gap Analysis

5 Global Neurovascular Devices Market, By Product

5.1 Introduction

5.1.1 Aneurysm Coiling & Embolization Devices

5.1.1.1 Embolic Coils

5.1.1.1.1 Detachable Coils

5.1.1.1.2 Pushable Coils

5.1.1.2 Flow Diversion Devices

5.1.1.3 Liquid Embolic

5.1.2 Neurothrombectomy Devices

5.1.2.1 Retrieval Systems

5.1.2.2 Suction and Aspiration Devices

5.1.3 Support Device

5.1.3.1 Microcatheters

5.1.3.2 Microguidewires

5.1.4 Cerebral Balloon Angioplasty and Stenting Systems

5.1.4.1 Carotid Artery Stents

5.1.4.2 Embolic Protection Systems

5.1.4.2.1 Balloon Occlusion Devices

5.1.4.2.2 Distal Filter Devices

6 Global Neurovascular Devices Market, By Therapeutic Application

6.1 Introduction

6.1.1 Hemorrhagic stroke

6.1.2 Ischemic Strokes

7 Global Neurovascular Devices Market, By End User

7.1 Introduction

7.1.1 Hospitals & Clinics

7.1.2 Ambulatory Surgical Units

8 Global Neurovascular Devices Market, By Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 U.S.

8.2.1.2 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 U.K

8.3.1.4 Italy

8.3.1.5 Spain

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 Republic of Korea

8.4.6 Rest of Asia Pacific

8.5 Middle East & Africa

8.5.1 United Arab Emirates

8.5.2 Saudi Arabia

8.5.3 Oman

8.5.4 Kuwait

8.5.5 Qatar

8.5.6 Rest of Middle East & Africa

9 Company Landscape

9.1 Company Share Analysis

10 Company Profiles

10.1 Stryker

10.1.1 Company Overview

10.1.2 Financials

10.1.3 Products

10.1.4 Strategy

10.1.5 Key Developments

10.2 Medtronic

10.2.1 Company Overview

10.2.2 Financials

10.2.3 Products

10.2.4 Strategy

10.2.5 Key Developments

10.3 Johnson & Johnson Services, Inc

10.3.1 Company Overview

10.3.2 Financials

10.3.3 Products

10.3.4 Strategy

10.3.5 Key Developments

10.4 TERUMO CORPORATION

10.4.1 Company Overview

10.4.2 Financials

10.4.3 Products

10.4.4 Strategy

10.4.5 Key Developments

10.5 Abbott

10.5.1 Company Overview

10.5.2 Financials

10.5.3 Products

10.5.4 Strategy

10.5.5 Key Developments

10.6 Merit Medical Systems, Inc.

10.6.1 Company Overview

10.6.2 Financials

10.6.3 Products

10.6.4 Strategy

10.6.5 Key Developments

10.7 Medikit co., ltd.

10.7.1 Company Overview

10.7.2 Financials

10.7.3 Products

10.7.4 Strategy

10.7.5 Key Developments

10.8 Penumbra, Inc.

10.8.1 Company Overview

10.8.2 Financials

10.8.3 Products

10.8.4 Strategy

10.8.5 Key Developments

10.9 MicroPort Scientific Corporatio

10.9.1 Company Overview

10.9.2 Financials

10.9.3 Products

10.9.4 Strategy

10.9.5 Key Developments

10.1 Evasc

10.10.1 Company Overview

10.10.2 Financials

10.10.3 Products

10.10.4 Strategy

10.10.5 Key Developments

10.11 Rapid Medical

10.11.1 Company Overview

10.11.2 Financials

10.11.3 Products

10.11.4 Strategy

10.11.5 Key Developments

11 Conclusion

11.1 Key Findings

11.1.1 CEO's Viewpoint

11.1.2 Key Companies to Watch

11.1.3 Prediction of NEUROVASCULAR Devices Industry

12 Appendix

12.1 Discussion Blue Print

12.2 References


List Of Figure

List of Figures:

FIGURE 1 GLOBAL NEUROVASCULAR DEVICES: MARKET STRUCTURE

FIGURE 2 RESEARCH METHODOLOGY

FIGURE 3 GLOBAL NEUROVASCULAR DEVICES MARKET: FORECAST MODEL

FIGURE 4 VALUE CHAIN: NEUROVASCULAR DEVICES MARKET

FIGURE 5 PORTERS FIVE FORCES MODEL: GLOBAL NEUROVASCULAR DEVICES MARKET

FIGURE 6 GLOBAL NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2017 & 2023 (USD MILLION)

FIGURE 7 GLOBAL NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)

FIGURE 8 GLOBAL NEUROVASCULAR DEVICES MARKET, BY END USER 2017 & 2023 (USD MILLION)

FIGURE 9 GLOBAL NEUROVASCULAR DEVICES MARKET, BY REGION 2017 & 2023 (USD MILLION)

FIGURE 10 AMERICAS NEUROVASCULAR DEVICES MARKET SHARE, BY REGION 2016 (%)

FIGURE 11 EUROPE NEUROVASCULAR DEVICES MARKET SHARE, BY COUNTRY 2016 (%)

FIGURE 12 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET SHARE, BY COUNTRY 2016 (%)

FIGURE 13 MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SHARE, BY COUNTRY 2016 (%)

FIGURE 14 GLOBAL NEUROVASCULAR DEVICES MARKET COMPANY SHARE ANALYSIS, 2016 (%)


List Of Table

List of Tables:

TABLE 1 PRIMARY INTERVIEWS

TABLE 2 GLOBAL NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 3 GLOBAL NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 4 GLOBAL NEUROVASCULAR DEVICES MARKET FOR ANEURYSM COILING & EMBOLIZATION DEVICES MARKET, BY REGION 2014-2023 (USD MILLION)

TABLE 5 GLOBAL NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 6 GLOBAL NEUROVASCULAR DEVICES MARKET FOR EMBOLIC COILS, BY REGION 2014-2023 (USD MILLION)

TABLE 7 GLOBAL NEUROVASCULAR DEVICES MARKET FOR DETACHABLE COILS, BY REGION 2014-2023 (USD MILLION)

TABLE 8 GLOBAL NEUROVASCULAR DEVICES MARKET FOR PUSHABLE COILS, BY REGION 2014-2023 (USD MILLION)

TABLE 9 GLOBAL NEUROVASCULAR DEVICES MARKET FOR FLOW DIVERSION DEVICES, BY REGION 2014-2023 (USD MILLION)

TABLE 10 GLOBAL NEUROVASCULAR DEVICES MARKET FOR LIQUID EMBOLIC, BY REGION 2014-2023 (USD MILLION)

TABLE 11 GLOBAL NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 12 GLOBAL NEUROVASCULAR DEVICES MARKET FOR NEUROTHROMBECTOMY DEVICES, BY REGION 2014-2023 (USD MILLION)

TABLE 13 GLOBAL NEUROVASCULAR DEVICES MARKET FOR RETRIEVAL SYSTEMS , BY REGION 2014-2023 (USD MILLION)

TABLE 14 GLOBAL NEUROVASCULAR DEVICES MARKET FOR SUCTION AND ASPIRATION DEVICES, BY REGION 2014-2023 (USD MILLION)

TABLE 15 GLOBAL NEUROVASCULAR DEVICES MARKET, SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 16 GLOBAL NEUROVASCULAR DEVICES MARKET FOR SUPPORT DEVICES, BY REGION 2014-2023 (USD MILLION)

TABLE 17 GLOBAL NEUROVASCULAR DEVICES MARKET FOR MICROCATHETERS, BY REGION 2014-2023 (USD MILLION)

TABLE 18 GLOBAL NEUROVASCULAR DEVICES MARKET FOR MICROGUIDEWIRES, BY REGION 2014-2023 (USD MILLION)

TABLE 19 GLOBAL NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 20 GLOBAL NEUROVASCULAR DEVICES MARKET FOR CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS, BY REGION 2014-2023 (USD MILLION)

TABLE 21 GLOBAL NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENTS, BY REGION 2014-2023 (USD MILLION)

TABLE 22 GLOBAL NEUROVASCULAR DEVICES MARKET, EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 23 GLOBAL NEUROVASCULAR DEVICES MARKET FOR EMBOLIC PROTECTION SYSTEMS, BY REGION 2014-2023 (USD MILLION)

TABLE 24 GLOBAL NEUROVASCULAR DEVICES MARKET FOR BALLOON OCCLUSION DEVICES, BY REGION 2014-2023 (USD MILLION)

TABLE 25 GLOBAL NEUROVASCULAR DEVICES MARKET FOR DISTAL FILTER DEVICES, BY REGION 2014-2023 (USD MILLION)

TABLE 26 GLOBAL NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 27 GLOBAL NEUROVASCULAR DEVICES MARKET FOR HEMORRHAGIC STROKE, BY REGION 2014-2023 (USD MILLION)

TABLE 28 GLOBAL NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES MARKET, BY REGION 2014-2023 (USD MILLION)

TABLE 29 GLOBAL NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 30 GLOBAL NEUROVASCULAR DEVICES MARKET FOR HOSPITALS & CLINICS MARKET, BY REGION 2014-2023 (USD MILLION)

TABLE 31 GLOBAL NEUROVASCULAR DEVICES MARKET FOR AMBULATORY SURGICAL UNITS MARKET, BY REGION 2014-2023 (USD MILLION)

TABLE 32 GLOBAL NEUROVASCULAR DEVICESCS MARKET, BY REGION 2014-2023 (USD MILLION)

TABLE 33 AMERICAS NEUROVASCULAR DEVICES MARKET, BY REGION 2014-2023 (USD MILLION)

TABLE 34 AMERICAS NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 35 AMERICAS NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 36 AMERICAS NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 37 AMERICAS NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 38 AMERICAS NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 39 AMERICAS NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 40 AMERICAS NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 41 AMERICAS NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 42 AMERICAS NEUROVASCULAR DEVICES, BY END USER 2014-2023 (USD MILLION)

TABLE 43 NORTH AMERICA NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2014-2023 (USD MILLION)

TABLE 44 NORTH AMERICA NEUROVASCULAR DEVICES, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 45 NORTH AMERICA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 46 NORTH AMERICA NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 47 NORTH AMERICA NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 48 NORTH AMERICA NEUROVASCULAR DEVICES, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 49 NORTH AMERICA NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 50 NORTH AMERICA NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 51 NORTH AMERICA NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 52 NORTH AMERICA NEUROVASCULAR DEVICES, BY END USER 2014-2023 (USD MILLION)

TABLE 53 U.S.NEUROVASCULAR DEVICES, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 54 U.S.NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 55 U.S.NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 56 U.S.NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 57 U.S.NEUROVASCULAR DEVICES, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 58 U.S.NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 59 U.S.NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 60 U.S.NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 61 U.S.NEUROVASCULAR DEVICES, BY END USER 2014-2023 (USD MILLION)

TABLE 62 CANADA NEUROVASCULAR DEVICES, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 63 CANADA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 64 CANADA NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 65 CANADA NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 66 CANADA NEUROVASCULAR DEVICES, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 67 CANADA NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 68 CANADA NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 69 CANADA NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 70 CANADA NEUROVASCULAR DEVICES, BY END USER 2014-2023 (USD MILLION)

TABLE 71 SOUTH AMERICA NEUROVASCULAR DEVICES, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 72 SOUTH AMERICA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 73 SOUTH AMERICA NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 74 SOUTH AMERICA NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 75 SOUTH AMERICA NEUROVASCULAR DEVICES, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 76 SOUTH AMERICA NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 77 SOUTH AMERICA NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 78 SOUTH AMERICA NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 79 SOUTH AMERICA NEUROVASCULAR DEVICES, BY END USER 2014-2023 (USD MILLION)

TABLE 80 EUROPE NEUROVASCULAR DEVICES MARKET, BY REGION 2014-2023 (USD MILLION)

TABLE 81 EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 82 EUROPE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 83 EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 84 EUROPE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 85 EUROPE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 86 EUROPE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 87 EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 88 EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 89 EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 90 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2014-2023 (USD MILLION)

TABLE 91 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 92 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 93 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 94 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 95 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 96 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 97 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 98 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 99 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 100 GERMANY NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 101 GERMANY NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 102 GERMANY NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 103 GERMANY NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 104 GERMANY NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 105 GERMANY NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 106 GERMANY NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 107 GERMANY NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 108 GERMANY NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 109 FRANCE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 110 FRANCE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 111 FRANCE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 112 FRANCE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 113 FRANCE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 114 FRANCE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 115 FRANCE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 116 FRANCE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 117 FRANCE NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 118 U.K NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 119 U.K NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 120 U.K NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 121 U.K NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 122 U.K NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 123 U.K NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 124 U.K NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 125 U.K NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 126 U.K NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 127 ITALY NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 128 ITALY NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 129 ITALY NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 130 ITALY NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 131 ITALY NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 132 ITALY NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 133 ITALY NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 134 ITALY NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 135 ITALY NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 136 SPAIN NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 137 SPAIN NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 138 SPAIN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 139 SPAIN NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 140 SPAIN NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 141 SPAIN NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 142 SPAIN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 143 SPAIN NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 144 SPAIN NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 145 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 146 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 147 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 148 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 149 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 150 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 151 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 152 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 153 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 154 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 155 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 156 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 157 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 158 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 159 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 160 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 161 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 162 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 163 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 164 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 165 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2014-2023 (USD MILLION)

TABLE 166 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 167 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 168 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 169 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 170 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 171 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 172 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 173 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 174 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 175 JAPAN NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 176 JAPAN NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 177 JAPAN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 178 JAPAN NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 179 JAPAN NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 180 JAPAN NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 181 JAPAN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 182 JAPAN NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 183 JAPAN NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 184 CHINA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 185 CHINA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 186 CHINA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 187 CHINA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 188 CHINA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 189 CHINA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 190 CHINA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 191 CHINA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 192 CHINA NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 193 INDIA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 194 INDIA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 195 INDIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 196 INDIA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 197 INDIA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 198 INDIA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 199 INDIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 200 INDIA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 201 INDIA NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 202 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 203 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 204 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 205 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 206 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 207 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 208 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 209 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 210 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 211 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 212 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 213 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 214 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 215 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 216 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 217 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 218 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 219 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 220 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 221 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 222 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 223 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 224 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 225 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 226 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 227 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 228 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 229 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2014-2023 (USD MILLION)

TABLE 230 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 231 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 232 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 233 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 234 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 235 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 236 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 237 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLUICATION 2014-2023 (USD MILLION)

TABLE 238 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY END USERM 2014-2023 (USD MILLION)

TABLE 239 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 240 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 241 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 242 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 243 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 244 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 245 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 246 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 247 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 248 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 249 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 250 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 251 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 252 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 253 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 254 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 255 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 256 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 257 OMAN NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 258 OMAN NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 259 OMAN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 260 OMAN NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 261 OMAN NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 262 OMAN NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 263 OMAN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 264 OMAN NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 265 OMAN NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 266 KUWAIT NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 267 KUWAIT NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 268 KUWAIT NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 269 KUWAIT NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 270 KUWAIT NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 271 KUWAIT NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 272 KUWAIT NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 273 KUWAIT NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 274 KUWAIT NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 275 QATAR NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 276 QATAR NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 277 QATAR NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 278 QATAR NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 279 QATAR NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 280 QATAR NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 281 QATAR NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 282 QATAR NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 283 QATAR NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 284 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 285 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 286 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 287 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 288 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 289 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 290 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 291 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 292 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

Licence Rights

"Single User License: OnIine PDF View Only
Enterprise-user License : Print & download option is available."

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Stryker, Johnson & Johnson Services, Inc., Medtronic, TERUMO CORPORATION, Merit Medical Systems, Inc., Abbott, Medikit co., ltd., MicroPort Scientific Corporation, Penumbra, Inc., Evasc, Neuravi, Rapid Medical, W. L. Gore & Associates, Inc., Sensome, OxfordEndovascular, Blockade Medical, LLC., Secant Group, LLC, Delaware Corporation, Gynesonics

Global Neurovascular Devices Market Research Report: Product (Aneurysm Coiling & Embolization Devices, Support Device) Therapeutic Application (Hemorrhagic & Ischemic Strokes) End-User (Hospitals, Ambulatory Surgical Units)-Global Forecast Till 2023

Market Analysis

For the treatment of neurovascular diseases like arteriovenous malformations (AVMs), brain aneurysm, and others, the neurovascular devices are used. With the expanding worldwide burden of the neurovascular illnesses and rising interest for negligibly invasive systems, the market for neurovascular gadgets was created. The market keeps on developing these reasonable stages. Furthermore, factors, for example, good repayment strategies, and continuous product development and commercialization drive market development. Hence, the global market for neurovascular devices is relied upon to develop at an exponential rate amid the forecast period (2017-2023).

Nevertheless, high procedural expense pursued by revealed instances of damage and the requirement for doctor preparing is assessed to control the market development amid the gauge time frame. It is accounted for that the normal expense for the treatment of neurovascular devices utilizing the flow diversion is assessed to be about USD 24,650. The Global Neurovascular Devices Market is projected to grow at a CAGR of 8.8% during forecast period.

Market Segmentation

The global neurovascular devices market is divided on the basis of product, end-user, therapeutic application, and regional analysis. Based on its product, the market is classified into embolization devices & aneurysm coiling, support device, neuro thrombectomy devices, stenting systems, and cerebral balloon angioplasty. Based on its therapeutic application, the global neurovascular devices market is categorized into ischemic strokes and hemorrhagic stroke. On the basis of the end-users industry, the market is classified into ambulatory surgical units and hospitals & clinics.

Regional Analysis

Geographically, the global neurovascular devices market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major Players

The industry players for the global neurovascular devices market include companies like Stryker, Johnson & Johnson Services, Inc., Medtronic, TERUMO CORPORATION, Merit Medical Systems, Inc., Abbott, Medikit co., ltd., MicroPort Scientific Corporation, Penumbra, Inc., Evasc, Neuravi, Rapid Medical, W. L. Gore & Associates, Inc., Sensome, OxfordEndovascular, Blockade Medical, LLC., Secant Group, LLC, Delaware Corporation, Gynesonics, among others.

READ MORE

Scope

Table of Contents:

1 Report Prologue

1.1 Introduction

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.4.1 Assumptions

1.4.2 Limitations

2 Research Methodology

2.1.1 Primary Research Methodology

2.1.2 Secondary Research Methodology

2.1.3 Market Share Analysis

2.1.4 Market Pricing Approach

3 Market Dynamics

3.1 Introduction

3.2 Drivers

3.2.1 Increasing prevalence of neurovascular diseases like brain aneurysm, arteriovenous malformations (AVMs), and others, will propel the neurovascular devices market

3.2.2 Favourable reimbursement policies provide favorable background for market growth

3.2.3 Rising demands for minimally invasive therapeutic procedures and growing geriatric population will drive the neurovascular devices market growth

3.2.4 Ongoing product development & commercialization will boost the neurovascular devices market

3.3 Restraints

3.3.1 High procedural cost by neurovascular devices

3.3.2 Cases of injury and need for physician training

3.4 Opportunity

3.5 Mega trend

3.5.1.1 Increasing use of endovascular embolization for the treatment of brain aneurysm

3.6 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Value Chain Analysis

4.1.1 R&D and Designing

4.1.2 Manufacturing

4.1.3 Distribution & Sales

4.1.4 Post-Sales Review

4.2 Porter's Five Forces Model

4.2.1 Bargaining Power of Suppliers

4.2.2 Bargaining Power of Buyers

4.2.3 Threat of New Entrants

4.2.4 Threat of Substitutes

4.2.5 Intensity of Rivalry

4.3 Investment Opportunities

4.4 Pricing Analysis

4.5 Demand & Supply: Gap Analysis

5 Global Neurovascular Devices Market, By Product

5.1 Introduction

5.1.1 Aneurysm Coiling & Embolization Devices

5.1.1.1 Embolic Coils

5.1.1.1.1 Detachable Coils

5.1.1.1.2 Pushable Coils

5.1.1.2 Flow Diversion Devices

5.1.1.3 Liquid Embolic

5.1.2 Neurothrombectomy Devices

5.1.2.1 Retrieval Systems

5.1.2.2 Suction and Aspiration Devices

5.1.3 Support Device

5.1.3.1 Microcatheters

5.1.3.2 Microguidewires

5.1.4 Cerebral Balloon Angioplasty and Stenting Systems

5.1.4.1 Carotid Artery Stents

5.1.4.2 Embolic Protection Systems

5.1.4.2.1 Balloon Occlusion Devices

5.1.4.2.2 Distal Filter Devices

6 Global Neurovascular Devices Market, By Therapeutic Application

6.1 Introduction

6.1.1 Hemorrhagic stroke

6.1.2 Ischemic Strokes

7 Global Neurovascular Devices Market, By End User

7.1 Introduction

7.1.1 Hospitals & Clinics

7.1.2 Ambulatory Surgical Units

8 Global Neurovascular Devices Market, By Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 U.S.

8.2.1.2 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 U.K

8.3.1.4 Italy

8.3.1.5 Spain

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 Republic of Korea

8.4.6 Rest of Asia Pacific

8.5 Middle East & Africa

8.5.1 United Arab Emirates

8.5.2 Saudi Arabia

8.5.3 Oman

8.5.4 Kuwait

8.5.5 Qatar

8.5.6 Rest of Middle East & Africa

9 Company Landscape

9.1 Company Share Analysis

10 Company Profiles

10.1 Stryker

10.1.1 Company Overview

10.1.2 Financials

10.1.3 Products

10.1.4 Strategy

10.1.5 Key Developments

10.2 Medtronic

10.2.1 Company Overview

10.2.2 Financials

10.2.3 Products

10.2.4 Strategy

10.2.5 Key Developments

10.3 Johnson & Johnson Services, Inc

10.3.1 Company Overview

10.3.2 Financials

10.3.3 Products

10.3.4 Strategy

10.3.5 Key Developments

10.4 TERUMO CORPORATION

10.4.1 Company Overview

10.4.2 Financials

10.4.3 Products

10.4.4 Strategy

10.4.5 Key Developments

10.5 Abbott

10.5.1 Company Overview

10.5.2 Financials

10.5.3 Products

10.5.4 Strategy

10.5.5 Key Developments

10.6 Merit Medical Systems, Inc.

10.6.1 Company Overview

10.6.2 Financials

10.6.3 Products

10.6.4 Strategy

10.6.5 Key Developments

10.7 Medikit co., ltd.

10.7.1 Company Overview

10.7.2 Financials

10.7.3 Products

10.7.4 Strategy

10.7.5 Key Developments

10.8 Penumbra, Inc.

10.8.1 Company Overview

10.8.2 Financials

10.8.3 Products

10.8.4 Strategy

10.8.5 Key Developments

10.9 MicroPort Scientific Corporatio

10.9.1 Company Overview

10.9.2 Financials

10.9.3 Products

10.9.4 Strategy

10.9.5 Key Developments

10.1 Evasc

10.10.1 Company Overview

10.10.2 Financials

10.10.3 Products

10.10.4 Strategy

10.10.5 Key Developments

10.11 Rapid Medical

10.11.1 Company Overview

10.11.2 Financials

10.11.3 Products

10.11.4 Strategy

10.11.5 Key Developments

11 Conclusion

11.1 Key Findings

11.1.1 CEO's Viewpoint

11.1.2 Key Companies to Watch

11.1.3 Prediction of NEUROVASCULAR Devices Industry

12 Appendix

12.1 Discussion Blue Print

12.2 References


List Of Figure

List of Figures:

FIGURE 1 GLOBAL NEUROVASCULAR DEVICES: MARKET STRUCTURE

FIGURE 2 RESEARCH METHODOLOGY

FIGURE 3 GLOBAL NEUROVASCULAR DEVICES MARKET: FORECAST MODEL

FIGURE 4 VALUE CHAIN: NEUROVASCULAR DEVICES MARKET

FIGURE 5 PORTERS FIVE FORCES MODEL: GLOBAL NEUROVASCULAR DEVICES MARKET

FIGURE 6 GLOBAL NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2017 & 2023 (USD MILLION)

FIGURE 7 GLOBAL NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2017 & 2023 (USD MILLION)

FIGURE 8 GLOBAL NEUROVASCULAR DEVICES MARKET, BY END USER 2017 & 2023 (USD MILLION)

FIGURE 9 GLOBAL NEUROVASCULAR DEVICES MARKET, BY REGION 2017 & 2023 (USD MILLION)

FIGURE 10 AMERICAS NEUROVASCULAR DEVICES MARKET SHARE, BY REGION 2016 (%)

FIGURE 11 EUROPE NEUROVASCULAR DEVICES MARKET SHARE, BY COUNTRY 2016 (%)

FIGURE 12 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET SHARE, BY COUNTRY 2016 (%)

FIGURE 13 MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SHARE, BY COUNTRY 2016 (%)

FIGURE 14 GLOBAL NEUROVASCULAR DEVICES MARKET COMPANY SHARE ANALYSIS, 2016 (%)


List Of Table

List of Tables:

TABLE 1 PRIMARY INTERVIEWS

TABLE 2 GLOBAL NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 3 GLOBAL NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 4 GLOBAL NEUROVASCULAR DEVICES MARKET FOR ANEURYSM COILING & EMBOLIZATION DEVICES MARKET, BY REGION 2014-2023 (USD MILLION)

TABLE 5 GLOBAL NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 6 GLOBAL NEUROVASCULAR DEVICES MARKET FOR EMBOLIC COILS, BY REGION 2014-2023 (USD MILLION)

TABLE 7 GLOBAL NEUROVASCULAR DEVICES MARKET FOR DETACHABLE COILS, BY REGION 2014-2023 (USD MILLION)

TABLE 8 GLOBAL NEUROVASCULAR DEVICES MARKET FOR PUSHABLE COILS, BY REGION 2014-2023 (USD MILLION)

TABLE 9 GLOBAL NEUROVASCULAR DEVICES MARKET FOR FLOW DIVERSION DEVICES, BY REGION 2014-2023 (USD MILLION)

TABLE 10 GLOBAL NEUROVASCULAR DEVICES MARKET FOR LIQUID EMBOLIC, BY REGION 2014-2023 (USD MILLION)

TABLE 11 GLOBAL NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 12 GLOBAL NEUROVASCULAR DEVICES MARKET FOR NEUROTHROMBECTOMY DEVICES, BY REGION 2014-2023 (USD MILLION)

TABLE 13 GLOBAL NEUROVASCULAR DEVICES MARKET FOR RETRIEVAL SYSTEMS , BY REGION 2014-2023 (USD MILLION)

TABLE 14 GLOBAL NEUROVASCULAR DEVICES MARKET FOR SUCTION AND ASPIRATION DEVICES, BY REGION 2014-2023 (USD MILLION)

TABLE 15 GLOBAL NEUROVASCULAR DEVICES MARKET, SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 16 GLOBAL NEUROVASCULAR DEVICES MARKET FOR SUPPORT DEVICES, BY REGION 2014-2023 (USD MILLION)

TABLE 17 GLOBAL NEUROVASCULAR DEVICES MARKET FOR MICROCATHETERS, BY REGION 2014-2023 (USD MILLION)

TABLE 18 GLOBAL NEUROVASCULAR DEVICES MARKET FOR MICROGUIDEWIRES, BY REGION 2014-2023 (USD MILLION)

TABLE 19 GLOBAL NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 20 GLOBAL NEUROVASCULAR DEVICES MARKET FOR CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS, BY REGION 2014-2023 (USD MILLION)

TABLE 21 GLOBAL NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENTS, BY REGION 2014-2023 (USD MILLION)

TABLE 22 GLOBAL NEUROVASCULAR DEVICES MARKET, EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 23 GLOBAL NEUROVASCULAR DEVICES MARKET FOR EMBOLIC PROTECTION SYSTEMS, BY REGION 2014-2023 (USD MILLION)

TABLE 24 GLOBAL NEUROVASCULAR DEVICES MARKET FOR BALLOON OCCLUSION DEVICES, BY REGION 2014-2023 (USD MILLION)

TABLE 25 GLOBAL NEUROVASCULAR DEVICES MARKET FOR DISTAL FILTER DEVICES, BY REGION 2014-2023 (USD MILLION)

TABLE 26 GLOBAL NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 27 GLOBAL NEUROVASCULAR DEVICES MARKET FOR HEMORRHAGIC STROKE, BY REGION 2014-2023 (USD MILLION)

TABLE 28 GLOBAL NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES MARKET, BY REGION 2014-2023 (USD MILLION)

TABLE 29 GLOBAL NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 30 GLOBAL NEUROVASCULAR DEVICES MARKET FOR HOSPITALS & CLINICS MARKET, BY REGION 2014-2023 (USD MILLION)

TABLE 31 GLOBAL NEUROVASCULAR DEVICES MARKET FOR AMBULATORY SURGICAL UNITS MARKET, BY REGION 2014-2023 (USD MILLION)

TABLE 32 GLOBAL NEUROVASCULAR DEVICESCS MARKET, BY REGION 2014-2023 (USD MILLION)

TABLE 33 AMERICAS NEUROVASCULAR DEVICES MARKET, BY REGION 2014-2023 (USD MILLION)

TABLE 34 AMERICAS NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 35 AMERICAS NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 36 AMERICAS NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 37 AMERICAS NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 38 AMERICAS NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 39 AMERICAS NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 40 AMERICAS NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 41 AMERICAS NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 42 AMERICAS NEUROVASCULAR DEVICES, BY END USER 2014-2023 (USD MILLION)

TABLE 43 NORTH AMERICA NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2014-2023 (USD MILLION)

TABLE 44 NORTH AMERICA NEUROVASCULAR DEVICES, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 45 NORTH AMERICA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 46 NORTH AMERICA NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 47 NORTH AMERICA NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 48 NORTH AMERICA NEUROVASCULAR DEVICES, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 49 NORTH AMERICA NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 50 NORTH AMERICA NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 51 NORTH AMERICA NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 52 NORTH AMERICA NEUROVASCULAR DEVICES, BY END USER 2014-2023 (USD MILLION)

TABLE 53 U.S.NEUROVASCULAR DEVICES, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 54 U.S.NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 55 U.S.NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 56 U.S.NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 57 U.S.NEUROVASCULAR DEVICES, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 58 U.S.NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 59 U.S.NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 60 U.S.NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 61 U.S.NEUROVASCULAR DEVICES, BY END USER 2014-2023 (USD MILLION)

TABLE 62 CANADA NEUROVASCULAR DEVICES, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 63 CANADA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 64 CANADA NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 65 CANADA NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 66 CANADA NEUROVASCULAR DEVICES, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 67 CANADA NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 68 CANADA NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 69 CANADA NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 70 CANADA NEUROVASCULAR DEVICES, BY END USER 2014-2023 (USD MILLION)

TABLE 71 SOUTH AMERICA NEUROVASCULAR DEVICES, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 72 SOUTH AMERICA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 73 SOUTH AMERICA NEUROVASCULAR DEVICES, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 74 SOUTH AMERICA NEUROVASCULAR DEVICES, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 75 SOUTH AMERICA NEUROVASCULAR DEVICES, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 76 SOUTH AMERICA NEUROVASCULAR DEVICES, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 77 SOUTH AMERICA NEUROVASCULAR DEVICES, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 78 SOUTH AMERICA NEUROVASCULAR DEVICES, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 79 SOUTH AMERICA NEUROVASCULAR DEVICES, BY END USER 2014-2023 (USD MILLION)

TABLE 80 EUROPE NEUROVASCULAR DEVICES MARKET, BY REGION 2014-2023 (USD MILLION)

TABLE 81 EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 82 EUROPE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 83 EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 84 EUROPE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 85 EUROPE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 86 EUROPE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 87 EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 88 EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 89 EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 90 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2014-2023 (USD MILLION)

TABLE 91 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 92 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 93 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 94 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 95 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 96 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 97 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 98 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 99 WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 100 GERMANY NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 101 GERMANY NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 102 GERMANY NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 103 GERMANY NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 104 GERMANY NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 105 GERMANY NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 106 GERMANY NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 107 GERMANY NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 108 GERMANY NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 109 FRANCE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 110 FRANCE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 111 FRANCE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 112 FRANCE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 113 FRANCE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 114 FRANCE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 115 FRANCE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 116 FRANCE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 117 FRANCE NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 118 U.K NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 119 U.K NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 120 U.K NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 121 U.K NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 122 U.K NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 123 U.K NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 124 U.K NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 125 U.K NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 126 U.K NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 127 ITALY NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 128 ITALY NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 129 ITALY NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 130 ITALY NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 131 ITALY NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 132 ITALY NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 133 ITALY NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 134 ITALY NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 135 ITALY NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 136 SPAIN NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 137 SPAIN NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 138 SPAIN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 139 SPAIN NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 140 SPAIN NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 141 SPAIN NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 142 SPAIN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 143 SPAIN NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 144 SPAIN NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 145 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 146 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 147 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 148 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 149 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 150 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 151 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 152 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 153 REST OF WESTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 154 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 155 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 156 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 157 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 158 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 159 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 160 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 161 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 162 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 163 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 164 EASTERN EUROPE NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 165 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2014-2023 (USD MILLION)

TABLE 166 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 167 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 168 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 169 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 170 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 171 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 172 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 173 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 174 ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 175 JAPAN NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 176 JAPAN NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 177 JAPAN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 178 JAPAN NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 179 JAPAN NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 180 JAPAN NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 181 JAPAN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 182 JAPAN NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 183 JAPAN NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 184 CHINA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 185 CHINA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 186 CHINA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 187 CHINA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 188 CHINA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 189 CHINA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 190 CHINA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 191 CHINA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 192 CHINA NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 193 INDIA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 194 INDIA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 195 INDIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 196 INDIA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 197 INDIA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 198 INDIA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 199 INDIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 200 INDIA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 201 INDIA NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 202 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 203 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 204 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 205 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 206 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 207 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 208 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 209 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 210 AUSTRALIA NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 211 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 212 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 213 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 214 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 215 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 216 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 217 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 218 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 219 REPUBLIC OF KOREA NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 220 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 221 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 222 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 223 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 224 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 225 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 226 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 227 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 228 REST OF ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 229 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY COUNTRY 2014-2023 (USD MILLION)

TABLE 230 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 231 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 232 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 233 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 234 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 235 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 236 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 237 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLUICATION 2014-2023 (USD MILLION)

TABLE 238 THE MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY END USERM 2014-2023 (USD MILLION)

TABLE 239 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 240 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 241 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 242 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 243 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 244 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 245 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 246 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 247 UNITED ARAB EMIRATES NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 248 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 249 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 250 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 251 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 252 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 253 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 254 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 255 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 256 SAUDI ARABIA NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 257 OMAN NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 258 OMAN NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 259 OMAN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 260 OMAN NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 261 OMAN NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 262 OMAN NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 263 OMAN NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 264 OMAN NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 265 OMAN NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 266 KUWAIT NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 267 KUWAIT NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 268 KUWAIT NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 269 KUWAIT NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 270 KUWAIT NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 271 KUWAIT NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 272 KUWAIT NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 273 KUWAIT NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 274 KUWAIT NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 275 QATAR NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 276 QATAR NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 277 QATAR NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 278 QATAR NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 279 QATAR NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 280 QATAR NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 281 QATAR NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 282 QATAR NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 283 QATAR NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

TABLE 284 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY PRODUCT 2014-2023 (USD MILLION)

TABLE 285 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY ANEURYSM COILING & EMBOLIZATION DEVICES 2014-2023 (USD MILLION)

TABLE 286 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC COILS 2014-2023 (USD MILLION)

TABLE 287 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY NEUROTHROMBECTOMY DEVICES 2014-2023 (USD MILLION)

TABLE 288 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY SUPPORT DEVICES 2014-2023 (USD MILLION)

TABLE 289 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS 2014-2023 (USD MILLION)

TABLE 290 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION SYSTEMS 2014-2023 (USD MILLION)

TABLE 291 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION 2014-2023 (USD MILLION)

TABLE 292 REST OF MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, BY END USER 2014-2023 (USD MILLION)

"Single User License: OnIine PDF View Only
Enterprise-user License : Print & download option is available."

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Stryker, Johnson & Johnson Services, Inc., Medtronic, TERUMO CORPORATION, Merit Medical Systems, Inc., Abbott, Medikit co., ltd., MicroPort Scientific Corporation, Penumbra, Inc., Evasc, Neuravi, Rapid Medical, W. L. Gore & Associates, Inc., Sensome, OxfordEndovascular, Blockade Medical, LLC., Secant Group, LLC, Delaware Corporation, Gynesonics